Viewing Study NCT01006369


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-02-08 @ 2:30 PM
Study NCT ID: NCT01006369
Status: COMPLETED
Last Update Posted: 2021-09-21
First Post: 2009-10-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Sponsor: Rutgers, The State University of New Jersey
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV colon cancer View
None stage IV rectal cancer View
None recurrent colon cancer View
None recurrent rectal cancer View